Blood clots form when three conditions converge: something changes in the blood itself, something damages or activates the vessel wall, and blood flow slows down or becomes turbulent. This framework, rooted in principles described over 150 years ago and still used by clinicians today, explains most clotting events, from a deep vein thrombosis in your leg to a heart attack triggered by a ruptured plaque in a coronary artery. What makes clotting so tricky to predict is that these three factors interact with each other, and no single abnormality reliably causes a clot on its own.
The Three Conditions That Set the Stage
Doctors still organize their thinking about clots around three overlapping categories: changes in the blood’s composition, damage to the blood vessel wall, and disrupted blood flow. These were originally grouped together as “Virchow’s triad,” and while the framework has been refined, it remains the backbone of how clotting is understood. Blood composition covers everything from how many platelets you have to the balance of proteins that promote or dissolve clots. Vessel wall abnormalities include damage from cholesterol plaques, inflammation, or infection. Blood flow matters because stagnant or slow-moving blood gives clotting proteins more time to accumulate at one spot.1PubMed Central. Procoagulant activity in hemostasis and thrombosis: Virchow’s triad revisited
The reason this matters practically is that clots rarely happen because of one isolated problem. A person might carry a genetic mutation that makes their blood slightly more prone to clotting, but they never develop a clot until they are bedridden after surgery and the flow in their leg veins slows to a crawl. Or someone with clean arteries might develop a clot after a severe infection that activates platelets and inflames vessel walls simultaneously. Risk factors for venous clots tilt this balance by slowing blood flow, lowering oxygen, activating the immune system, or shifting the concentrations of pro- and anticoagulant proteins.2PubMed. Mechanistic view of risk factors for venous thromboembolism
Arterial Clots Versus Venous Clots
Not all blood clots are the same. The clots that cause heart attacks and most strokes form in arteries, while the clots associated with deep vein thrombosis and pulmonary embolism form in veins. These two types have traditionally been treated as very different problems, and to some degree they are. Arterial clots tend to form in the setting of atherosclerosis, where a cholesterol-laden plaque in the vessel wall ruptures and exposes material that triggers rapid platelet clumping and clot formation.3PubMed. Mechanisms of plaque vulnerability and rupture Venous clots, by contrast, more often result from sluggish blood flow combined with activation of the body’s clotting cascade.
Under a microscope, the structural differences are real but less dramatic than textbooks once suggested. Arterial clots are made mostly of fibrin (about 43% of volume) and platelets (about 31%), while venous clots are dominated by red blood cells (about 63%) and fibrin fibers (about 35%), with very little platelet content.4Scientific Reports. The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli The old shorthand of “white” arterial clots and “red” venous clots captures this general trend. But both types share the same basic ingredients; the difference is in their proportions, driven largely by whether blood flow at the site is fast (arteries) or slow (veins).5PubMed. Venous and Arterial Thromboses: Two Sides of the Same Coin?
What Triggers an Arterial Clot
The most common scenario for an arterial clot starts with atherosclerosis, the gradual buildup of fatty plaques inside artery walls. Not all plaques are equally dangerous. The ones most likely to cause a sudden clot have a large, soft core of cholesterol and dead cells covered by an extremely thin fibrous cap. When that cap tears open, the contents inside are highly thrombogenic, meaning they instantly recruit platelets and activate the clotting cascade.6PubMed. Mechanisms of plaque formation and rupture The resulting clot can partially or completely block the artery within minutes.
Plaque rupture is a mechanical and biological event. The cap has to bear increased stress at certain points, and weakening of the structural material at those sites leads to tearing.7Cardiovascular Research. Mechanisms of plaque rupture: mechanical and biologic interactions This is why risk factors for heart attack and stroke overlap so heavily with factors that promote inflammation and damage to artery walls: high blood pressure, smoking, diabetes, and high cholesterol all contribute to making plaques larger and less stable.
Genetic Factors That Shift the Balance
Some people are born with blood that clots more easily than average. The most well-known inherited condition is factor V Leiden, a mutation in one of the proteins involved in the clotting cascade. Carrying one copy of the mutation raises your risk of a venous clot roughly sevenfold compared to the general population. Carrying two copies raises the risk about 80-fold, meaning most people with two copies will experience at least one clotting event in their lifetime.8Blood. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
Factor V Leiden is the most common inherited clotting disorder in people of European descent, present in roughly 3 to 8 percent of that population. Other inherited conditions that increase clot risk include prothrombin gene mutations and deficiencies in natural anticoagulant proteins like protein C, protein S, and antithrombin. These conditions don’t guarantee a clot. Many carriers go their entire lives without one. But they lower the threshold, so when a second risk factor comes along, like surgery, pregnancy, or prolonged immobility, a clot becomes much more likely.
Acquired Risk Factors You Can and Cannot Control
Beyond genetics, a long list of situational and medical factors raise clot risk. Some are modifiable; others come with a particular life stage or medical condition.
- Immobility: Sitting or lying still for extended periods slows venous blood flow in the legs. Long-haul air travel has been associated with a higher incidence of deep vein thrombosis and pulmonary embolism during or within 48 hours of the flight.9PubMed Central. The secret enemy during a flight: Economy class syndrome Hospitalization and bed rest carry the same risk through the same mechanism.
- Surgery and trauma: Any procedure that damages tissue releases substances that activate clotting. Major orthopedic surgeries, particularly hip and knee replacements, are among the highest-risk events.
- Obesity: Excess body weight increases pressure in the veins of the pelvis and legs and is associated with a more pro-inflammatory blood environment.
- Dehydration: When you lose fluid without replacing it, your blood becomes more concentrated. Animal models show a significant increase in clot tendency during dehydration, and clinical interest in this factor has been studied in the context of air travel, bariatric surgery, and stroke.10PubMed Central. Extensive Lower Limb Deep Vein Thrombosis Provoked by Gastroenteritis-Induced Dehydration: A Case Report for Unusual Precipitating Factor
- Smoking: Damages the endothelial lining of arteries and promotes atherosclerosis and platelet activation.
These factors frequently stack. A person who is overweight, takes a long flight while slightly dehydrated, and has an undiagnosed factor V Leiden mutation is layering several risks at once. That stacking effect explains why some people develop a clot after a seemingly ordinary event while others with similar exposure never do.
Hormonal Influences
Estrogen-containing medications, including combined oral contraceptives and hormone replacement therapy, are among the most common acquired risk factors for venous clots in younger women. Estrogen shifts the blood’s clotting balance by increasing levels of several clotting factors, including fibrinogen, prothrombin, factor V, and factor X, while decreasing antithrombin III, a natural anticoagulant protein.11PubMed. Effects of oral contraceptives containing 50 microgram estrogen on blood coagulation in non-Caucasian women The net effect is a modest tilt toward a more clot-friendly state.
For most women, the absolute risk of a clot from oral contraceptives remains low. But the risk compounds sharply in women who also carry a genetic clotting disorder. A woman with factor V Leiden who takes a combined oral contraceptive faces a far higher clot risk than either factor alone would predict. This is one reason some doctors recommend testing for inherited clotting disorders before prescribing estrogen-containing contraception, especially if there is a family history of venous clots. Pregnancy itself also raises clot risk through hormonal shifts, increased blood volume, and compression of pelvic veins by the growing uterus.
Cancer and Clotting
The link between cancer and blood clots has been recognized for over a century. Venous clot risk is roughly four times higher in people with cancer than in the general population, and an underlying malignancy accounts for an estimated 10 to 20 percent of all deep vein thrombosis cases.12Mayo Clinic Proceedings. Trousseau Syndrome and the Unknown Cancer: Use of Positron Emission Tomographic Imaging in a Patient With a Paraneoplastic Syndrome Sometimes an unexplained clot is even the first sign that a cancer exists.
Cancers promote clotting through several routes: tumors can release substances that directly activate the clotting cascade, they provoke inflammation that damages vessel walls, and they alter the balance of pro- and anticoagulant proteins in the blood. The cancers most commonly associated with this phenomenon include those of the pancreas, lung, prostate, stomach, and colon, with pancreatic cancer alone accounting for about half of all cases of cancer-related clotting syndromes.12Mayo Clinic Proceedings. Trousseau Syndrome and the Unknown Cancer: Use of Positron Emission Tomographic Imaging in a Patient With a Paraneoplastic Syndrome Chemotherapy and surgery further increase the risk. For patients with active cancer, clot prevention is a constant clinical concern.
When the Immune System Drives Clotting
The immune system and the clotting system are far more intertwined than was appreciated even a couple of decades ago. White blood cells called neutrophils can release webs of DNA and proteins, known as neutrophil extracellular traps, when triggered by infection or inflammation. These traps are meant to catch and kill bacteria, but they also snare platelets and clotting proteins, promoting thrombus formation as a side effect.13PubMed Central. Neutrophil extracellular traps mediate neuro-immunothrombosis This crossover between immunity and clotting, sometimes called immunothrombosis, helps explain why severe infections, sepsis, and inflammatory conditions carry elevated clot risk.
A more specific example is antiphospholipid syndrome, an autoimmune condition in which the body produces antibodies that activate endothelial cells, platelets, and neutrophils. These antibodies alter clot structure, producing denser fibrin networks that are harder for the body to dissolve.14PubMed Central. The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System Antiphospholipid syndrome can cause both venous and arterial clots and is a common culprit behind unexplained clots in younger adults, recurrent pregnancy loss, and strokes with no obvious risk factors.
Warning Signs That a Clot Has Formed
A clot that forms inside a deep leg vein often announces itself with swelling, pain, warmth, and redness in one leg, usually the calf or thigh. The symptoms typically affect one side. But in a meaningful number of cases, deep vein thrombosis produces few or no symptoms at all, which is part of what makes it dangerous. Some clots are discovered only when a piece breaks off and travels to the lungs.
A pulmonary embolism, where a clot lodges in the lung’s blood vessels, produces a different set of warning signs: sudden shortness of breath, chest pain that worsens with deep breaths, a rapid heartbeat, and sometimes coughing up blood. In a study comparing patients who had deep vein thrombosis alone with those who also had a pulmonary embolism, patients with pulmonary embolism were more likely to have clots higher up in the leg (proximal rather than calf-level), and they were actually less likely to have had obvious leg symptoms beforehand.15PubMed. Venous thromboembolism: deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, and pulmonary embolism alone That disconnect is important: the absence of leg symptoms does not rule out a dangerous clot.
Arterial clots produce symptoms based on which organ they starve of blood. A clot in a coronary artery causes chest pressure, pain radiating to the arm or jaw, and shortness of breath. A clot in a brain artery causes sudden weakness on one side, slurred speech, or vision changes. Because arterial clots tend to form and obstruct quickly, these symptoms usually hit without much buildup.
How Clots Are Detected
When doctors suspect a venous clot, the workup usually starts with a blood test called D-dimer, which measures a protein fragment released when a clot dissolves. A normal D-dimer level is useful because it makes a clot very unlikely. The test’s negative predictive value for proximal deep vein thrombosis reaches about 99%, meaning a negative result strongly argues against a large clot.16PubMed. Age-adjusted D-dimer, clinical pre-test probability-adjusted D-dimer, and whole leg ultrasound in ruling out suspected proximal and calf deep venous thrombosis The catch is that D-dimer goes up for many reasons besides clots, including infection, surgery, pregnancy, cancer, and simply getting older. Its specificity with a standard cutoff is only about 47%, which means more than half of people with an elevated D-dimer do not actually have a clot.
To improve accuracy, some centers use age-adjusted or clinical probability-adjusted D-dimer thresholds, which can reduce unnecessary imaging by letting more low-risk patients be cleared with blood work alone.16PubMed. Age-adjusted D-dimer, clinical pre-test probability-adjusted D-dimer, and whole leg ultrasound in ruling out suspected proximal and calf deep venous thrombosis If the D-dimer is elevated or the clinical suspicion is high, an ultrasound of the leg veins is the next step. For pulmonary embolism, CT imaging of the chest with contrast dye is the standard confirmatory test.
Long-Term Consequences of a Clot
A clot is not just an acute event. Even after the immediate danger passes, there can be lasting damage. Post-thrombotic syndrome develops in a significant fraction of people who have had a deep vein thrombosis. The clot, even after it is treated, can scar the vein wall and damage the one-way valves that normally keep blood flowing upward. The result is chronic pain, swelling, skin discoloration, and in severe cases, open sores (venous ulcers) on the lower leg.17PubMed. Post-thrombotic syndrome and chronic thromboembolic pulmonary hypertension: diagnosis and management
When a pulmonary embolism leaves behind organized clot material in the lung’s arteries, it can lead to chronic thromboembolic pulmonary hypertension, a condition where the right side of the heart has to work progressively harder to push blood through the lungs. Symptoms range from breathlessness on exertion to outright heart failure.17PubMed. Post-thrombotic syndrome and chronic thromboembolic pulmonary hypertension: diagnosis and management Both complications underscore why preventing a first clot is preferable to treating one after it happens.
Prevention Beyond Medication
Blood-thinning drugs get the most attention for clot prevention, but non-drug approaches play a large role, especially in hospitals. Intermittent pneumatic compression devices, the inflatable sleeves placed around the calves of patients during and after surgery, work by physically squeezing blood through the veins at higher velocity, reducing the stagnation that invites clot formation. In critically ill patients, the incidence of both deep vein thrombosis and overall venous thromboembolism was lower in patients who received compression compared to controls.18PubMed. Intermittent Pneumatic Compression to Prevent Venous Thromboembolism in Critically Ill Adult Patients The devices also appear to produce measurable changes in the blood’s clotting profile, though the exact nature and clinical significance of those changes still need more study.19PubMed. Haematological Effects of Intermittent Pneumatic Compression for Deep Vein Thrombosis Prophylaxis
Outside the hospital, the basics of clot prevention for most people are surprisingly unglamorous: stay reasonably active, get up and walk periodically during long trips, stay hydrated, maintain a healthy weight, and avoid smoking. For people on long flights, flexing your calves and getting up to walk the aisle every hour or two is the simplest preventive measure available. Compression stockings are sometimes recommended for higher-risk travelers or those with a history of venous clots.
Clots at the Extremes of Age
Clotting risk is not evenly distributed across the lifespan. In newborns, the clotting system is still developing. Healthy newborns manage fine, with a stable balance despite having different levels of clotting proteins than adults. But when a sick newborn is exposed to additional risk factors, especially a central venous catheter, the balance can tip toward thrombosis. Central venous catheters are the single most important risk factor for clots in neonates.20PubMed Central. Developmental Hemostasis and Management of Central Venous Catheter Thrombosis in Neonates
At the other end of the age spectrum, clot risk rises steeply with age. Older adults are more likely to have multiple risk factors piled together: reduced mobility, chronic diseases, cancer, and age-related changes in blood vessel walls and clotting protein levels. The rising D-dimer levels seen with normal aging complicate diagnosis, which is why age-adjusted D-dimer thresholds have been developed to avoid sending every older adult with a mildly elevated level for imaging.
When a Clot Crosses Between Heart Chambers
About one in four adults has a small opening between the upper chambers of the heart called a patent foramen ovale (PFO). In most people, this opening causes no problems. But in some, a clot that forms in a vein can pass through the PFO and travel directly into the arterial circulation, potentially reaching the brain and causing a stroke. This “paradoxical embolism” is frequently identified in younger patients who have a stroke with no obvious arterial cause.21PubMed Central. European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke
Clot formation can also occur within the PFO itself, and the structural abnormality may promote atrial arrhythmias that independently raise stroke risk.21PubMed Central. European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke When a young person has a stroke and a PFO is found, the decision about whether to close it with a catheter-based procedure depends on whether the PFO is judged to have actually contributed to the event. This remains an evolving and sometimes debated area, with European guidelines now providing structured criteria for when closure is recommended.